Agilent Q4 Revenues Climb 35 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today reported revenues for its fiscal 2010 fourth quarter of $1.58 billion, up 35 percent from a year ago and surpassing analyst estimates of $1.52 billion.

A year ago, the company posted revenues $1.17 billion. Excluding the effects of the Varian acquisition and recent divestitures, revenues for the three months ended Oct. 31 were up 26 percent, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.